Galanin antagonist increases insulin resistance by reducing glucose transporter 4 effect in adipocytes of rats

General and Comparative Endocrinology

Volumn 173, Issue 1, 2011, Pages 159-163

  Guo, Lili ^b   Shi, Mingyi ^a   Zhang, Ling ^a   Li, Guangzhi ^a   Zhang, Lingxiang ^a   Shao, Hu ^a   Fang, Penghua ^a   Ma, Yingping ^a   Li, Jian ^a   Shi, Qiaojia ^a   Sui, Yumei ^a  

^a YANGZHOU UNIVERSITY   (China)

^b Chuzhou College   (China)

Author keywords

Adipose; Galanin; Glucose transport; GLUT4

Indexed keywords

GALANIN; GLUCOSE TRANSPORTER 4; MESSENGER RNA;

ADIPOCYTE; ADIPOCYTE MEMBRANE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; EXERCISE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; IMMUNOREACTIVITY; INFUSION RATE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRACELLULAR MEMBRANE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN TRANSPORT; RAT; SWIMMING;

EID: 79959879182     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2011.05.011     Document Type: Article

References (26)

1. Adams A.C., Clapham J.C., Wynick D., Speakman J.R. Feeding behaviour in galanin knockout mice supports a role of galanin in fat intake and preference. J. Neuroendocrinol. 2008, 20:199-206.
2. Adeghate E., Ponery A.S. Large reduction in the number of galanin-immunoreactive cells in pancreatic islets of diabetic rats. Neuroendocrinology 2001, 13:706-710.
3. Ahren B., Pacini G., Wynick D., Wierup N., Sundler F. Loss of function mutation of the galanin gene is associated with perturbed islet function in mice. Endocrinology 2004, 145:3190-3196.
4. Augustin R. The protein family of glucose transport facilitators: it's not only about glucose after all, IUBMB. Life 2010, 62:315-333.
5. Beard K.M., Lu H., Ho K., Fantus I.G. Bradykinin augments insulin-stimulated glucose transport in rat adipocytes via endothelial nitric oxide synthase-mediated inhibition of Jun NH2-terminal kinase. Diabetes 2006, 55:2678-2687.
6. Bonen A., Dohm G.L., van Loon L.J. Lipid metabolism, exercise and insulin action. Essays Biochem. 2006, 42:47-59.
7. Cheng H., Straub S.G., Sharp G.W. Protein acylation in the inhibition of insulin secretion by norepinephrine, somatostatin, GAL and PGE2. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E287-E294.
8. Geiger P.C., Han D.H., Wright D.C., Holloszy J.O. How muscle insulin sensitivity is regulated: testing of a hypothesis. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E1258-E1263.
9. Graham T.E., Yang Q., Blüher M., Hammarstedt A., Ciaraldi T.P., Henry R.R., Wason C.J., Oberbach A., Jansson P.A., Smith U., Kahn B.B. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med. 2006, 354:2552-2563.
10. He B., Shi M.Y., Zhang L., Li G.Z., Zhang L.X., Shao H., Li J., Fang P.H., Ma Y.P., Shi Q.J., Sui Y.M. Beneficial effect of galanin on insulin sensitivity in muscle of type 2 diabetic rats. Physiol. Behav. 2011, 103:284-289.
11. Hohmann J.G., Teklemichael D.N., Weinshenker D., Wynick D., Clifton D.K., Steiner R.A. Obesity and endocrine dysfunction in mice with deletions of both neuropeptide Y and galanin. Mol. Cell. Biol. 2004, 24:2978-2985.
12. Jiang L., Shi M.Y., Guo L.L., He B., Li G.Z., Zhang L., Zhang L.X., Shao H. Effect of M35, a neuropeptide galanin antagonist on glucose uptake translated by glucose transporter 4 in trained rat skeletal muscle. Neurosci. Lett. 2009, 467:178-181.
13. Komatsu T., Itoh F., Mikawa S., Hodate K. Gene expression of resistin in adipose tissue and mammary gland of lactating and non-lactating cows. J. Endocrinol. 2003, 178:R1-R5.
14. Krammer D.K., Al-Khalili L., Guigas B., Leng Y., Garcia-Roves P.M., Krook A. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle. J. Biol. Chem. 2007, 282:19313-19320.
15. Lang R., Gundlach A.L., Kofler B. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol. Ther. 2007, 115:177-207.
16. Legalkis I.N. The role of galanin in metabolic disorders leading to type 2 diabetes mellitus. Drug News Perspect. 2005, 18:173-177.
17. Legalkis I.N., Mantzouridis T., Mountokalakis T. Positive correlation of galanin with glucose in healthy volunteers during an oral glucose tolerance test. Horm. Metab. Res. 2007, 39:53-55.
18. Li R.Y., Song H.D., Shi W.J., Hu S.M., Yang Y.S., Tang J.F., Chen M.D., Chen J.L. Galanin inhibits leptin expression and secretion in rat adipose tissue and 3T3-L1 adipocytes. J. Mol. Endocrinol. 2004, 33:11-19.
19. Lumeng C.N., Deyoung S.M., Saltiel A.R. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E166-E174.
20. Milot M., Trudeau F. Plasma galanin immunoreactivity in the rat after swimming. Physiol. Behav. 1997, 62:697-700.
21. Poritsanos N.J., Mizuno T.M., Lautatzis M.-E., Vrontakis M. Chronic increase of circulating galanin levels induces obesity and marked alterations in lipid metabolism similar to metabolic syndrome. Int. J. Obes. 2009, 33:1381-1389.
22. Sakamoto K., Holman G.D. Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E29-E37.
23. Shepherd P.R., Kahn B.B. Glucose transporters and insulin action implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 1999, 341:248-257.
24. Stuart W.I., de Heredia F.P., Wang B., Trayhurn P. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc. Nutr. Soc. 2009, 68:370-377.
25. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol. Scand. 2005, 184:285-293.
26. Zdrojewicz Z., Sowińska E. The significance of galanin in physiologic and pathologic processes in humans. Poste. Hig. Med. Dosw. 2000, 54:819-833.